These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Developments in blood transfusion]. Krusius T; Porkka K Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306 [No Abstract] [Full Text] [Related]
4. [Various methods for good blood supply in Scandinavia]. Oldinger E Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533 [No Abstract] [Full Text] [Related]
5. Transfusion medicine issues in the practice of anesthesiology. Robblee JA; Crosby E Transfus Med Rev; 1995 Jan; 9(1):60-78. PubMed ID: 7719039 [No Abstract] [Full Text] [Related]
6. Common problems in blood transfusion. Nour-Eldin F Practitioner; 1976 Jan; 216(1291):64-72. PubMed ID: 772656 [TBL] [Abstract][Full Text] [Related]
7. GMP in blood collection and processing. Wagstaff W Vox Sang; 1998; 74 Suppl 2():513-21. PubMed ID: 9704492 [TBL] [Abstract][Full Text] [Related]
8. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Mahony BO; Turner A Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697 [No Abstract] [Full Text] [Related]
9. Is there a limit to the normality of blood products? Hughes WG Hematol J; 2001; 2(3):212. PubMed ID: 11920249 [No Abstract] [Full Text] [Related]
10. International views on universal leucodepletion: the perspective in Germany. Seitz MD Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155 [No Abstract] [Full Text] [Related]
11. ISBT Board response to the Dublin consensus statement. Flanagan P Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536 [No Abstract] [Full Text] [Related]
12. [Evolution of the practices of labile blood product distribution]. Tardivel R Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509 [No Abstract] [Full Text] [Related]
13. [State and perspectives of the French haemovigilance system. Presentation of the data collected over 9 years]. David B Transfus Clin Biol; 2003 Jun; 10(3):131-9. PubMed ID: 12798845 [No Abstract] [Full Text] [Related]
14. [Scandinavian recommendations for transfusion medicine]. Eklund J; Jørgensen J; Högman C; Jensson O; Kornstad L Nord Med; 1991; 106(11):299-300. PubMed ID: 1945807 [TBL] [Abstract][Full Text] [Related]
15. [Quality indicators and dashboards: the experience of a collection department]. Danic B; Bécel C; Beauplet A Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662 [TBL] [Abstract][Full Text] [Related]
16. Quality assurance of blood components prepared in the blood transfusion center/blood bank. Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467 [No Abstract] [Full Text] [Related]
17. [Control of the quality of blood grouping]. Habibi B; Salmon C Rev Fr Transfus Immunohematol; 1979 Feb; 22(1):83-92. PubMed ID: 493794 [No Abstract] [Full Text] [Related]
18. [Immunobiology--the neglected side of transfusion]. Flesland O; Solheim BG Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2493. PubMed ID: 11070981 [No Abstract] [Full Text] [Related]
19. Validation approaches selective/universal leucodepletion: the need for standardised validation strategies. Seghatchian MJ; Krailadsiri P Transfus Sci; 1998 Dec; 19(4):363-5. PubMed ID: 10351157 [No Abstract] [Full Text] [Related]
20. International views on universal leucodepletion: the perspective in The Netherlands. de Wit HC Transfus Sci; 1998 Dec; 19(4):353-4. PubMed ID: 10351153 [No Abstract] [Full Text] [Related] [Next] [New Search]